Biotech stocks plunge and in­dus­try fig­ures left to won­der af­ter Prasad's FDA ap­point­ment

How did bio­phar­ma stocks re­act to Vinay Prasad’s ap­point­ment as di­rec­tor of one of the FDA’s top jobs? Not well.

Prasad, a hema­tol­o­gist-on­col­o­gist by train­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER